Pacira BioSciences Reports Director/Officer Changes & More
Ticker: PCRX · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, board-of-directors, officer-appointments
Related Tickers: PCRX
TL;DR
Pacira BioSciences (PCRX) filed an 8-K detailing director/officer changes, elections, and executive compensation updates.
AI Summary
Pacira BioSciences, Inc. filed an 8-K on June 13, 2025, reporting on events that occurred on June 10, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes the submission of matters to a vote of security holders and financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate governance and executive changes at Pacira BioSciences, which could impact the company's strategic direction and operational leadership.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with executive compensation details, can signal shifts in company strategy or internal dynamics that may affect future performance.
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- June 10, 2025 (date) — Earliest event reported
- June 13, 2025 (date) — Date of report
FAQ
What specific director or officer positions were affected by the changes reported in the 8-K?
The filing indicates the "Departure of Directors or Certain Officers" and "Appointment of Certain Officers" but does not specify the names or exact positions in the provided text.
Were there any new directors elected to the board?
Yes, the filing lists "Election of Directors" as an item of information reported.
What type of compensatory arrangements for officers are detailed in this filing?
The filing mentions "Compensatory Arrangements of Certain Officers" but the specific details of these arrangements are not provided in the excerpt.
Were any matters submitted to a vote of security holders?
Yes, the filing explicitly states "Submission of Matters to a Vote of Security Holders" as an item of information.
What financial statements or exhibits are included with this 8-K filing?
The filing indicates "Financial Statements and Exhibits" are included, but the specific content is not detailed in the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Pacira BioSciences, Inc. (PCRX).